A recent study found that LGBT adults are less likely than non-LGBT adults to take drugs that prevent heart disease, reports the LGBTQ Nation.
The study, published this week in the Journal of the American Heart Association (AHA), surveyed 1,531 people aged 40 and over. He found that less than 21% of LGB adults were taking cholesterol-lowering drugs, known as “statins,” compared with about 44 percent of those who did not identify themselves as LGBT.
The data from this unprecedented study is especially important, due to the fact that the AHA has found that LGBT adults are already at an increased risk of heart disease, according to the American Heart Association.
This increased risk comes from the additional stressors that LGBT people experience throughout their lives, as well as the fact that LGBT people are more likely to drink alcohol, smoke, use drugs or deal with obesity.
The study also found, however, that there was no difference in statin use between LGBT adults and non-LGBT adults who already had heart disease.
One of the study’s authors, Yi Guo, said there are a number of possible explanations for the disparity between preventive use of statins, including the fact that LGBT people may not visit the doctor as often as non-LGBT people. This means that doctors do not have as many opportunities to recommend statins to the LGBT population.
Guo also emphasized an “urgent need for personalized interventions and campaigns” that promote awareness of the LGBT community about the importance of statins and cardiovascular health in general.
Another study author, Jiang Bian, said it is important for healthcare professionals “to address their own prejudices and understand the complexities of LGB patients, making sure to provide policy-oriented recommendations in a culturally competent way”.